“…This data correlates with prior observational and small prospective randomized trials that have demonstrated pacemaker therapy efficacy in reducing recurrent syncope in the elderly. [18][19][20][21] Historically, however, unblinded trials in the therapy of syncope have provided divergent results, 22 reinforcing the need for large doubleblinded randomized approaches in this field. These results should also, however, be seen in the context of the Safepace 2 trial, 23 which, although double-blinded (yet underpowered), did only show a trend toward benefit with pacing versus implantable loop recording.…”